Effect of the synthetic immunomodulator, linomide, on experimental models of thyroiditis

Immunology

Volumn 96, Issue 3, 1999, Pages 340-347

  Hutchings, P ^a   Hedlund, G ^b   Dawe, K ^b   Howlett, S ^a   Cooke, A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Lund Research Center   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; FREUND ADJUVANT; IMMUNOMODULATING AGENT; LIPOPOLYSACCHARIDE; ROQUINIMEX; THYROGLOBULIN; THYROGLOBULIN ANTIBODY;

ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HASHIMOTO DISEASE; IMMUNOMODULATION; INFLAMMATORY INFILTRATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIALOADENITIS; THYROIDITIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FREUND'S ADJUVANT; HYDROXYQUINOLINES; LIPOPOLYSACCHARIDES; LYMPH NODES; MALE; MICE; MICE, INBRED CBA; MICE, INBRED NOD; SIALADENITIS; THYROGLOBULIN; THYROIDITIS, AUTOIMMUNE;

EID: 0033014038     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00713.x     Document Type: Article

References (34)

1. DAWE K., HUTCHINGS P.R., CHAMPION B., COOKE A. & ROITT I.M. (1993) Autoantigens in thyroid disease. Springer Semin Immunopathol 14, 285.
2. ESQUIVEL P.S., ROSE N.R. & KONG Y.-C.M. (1977) Induction of autoimmunity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide. J Exp Med 145, 1250.
3. HUTCHINGS P.R., COOKE A., DAWE K. et al. (1992) A thyroxine-containing peptide can induce murine experimental autoimmune thyroiditis. J Exp Med 175, 869.
4. FLYNN J.C., CONAWAY D.H., COBBOLD S., WALDMANN H. & KONG Y.-C.M. (1989) Depletion of L3T4+ and Lyt-2+ cells by rat monoclonal antibodies alters the development of adoptively transferred experimental autoimmune thyroiditis. Cell Immunol 122, 377.
5. DAMOTTE D., COLOMB E., CAILLEAU C., BROUSSE N., CHARREIRE J. & CARNAUD C. (1997) Analysis of susceptibility of NOD mice to spontaneous and experimentally induced thyroiditis. Eur J Immunol 27, 2854.
6. STULL S.J., SHARP G.C., KYRIAKOS M., BICKEL J.T. & BRALEY-MULLEN H. (1992) Induction of granulomatous experimental autoimmune thyroiditis in mice with in vitro activated effector T cells and anti-IFN-γ antibody. J Immunol 149, 2219.
7. PODOLIN P.L., PRESSEY A., DELAROTO N.H., FISCHER P.A., PETERSON L.B. & WICKER L.S. (1993) I-E+ Nonobese diabetic mice develop insulitis and diabetes. J Exp Med 178, 793.
8. h4 mice. Clin Immunol Immunopathol 81, 287.
9. GOILLOT E., MUTIN M. & TOURAINE J.L. (1991) Sialadenitis in nonobese diabetic mice: transfer into healthy neonates by splenic T lymphocytes. Clin Immunol Immunopathol 59, 462.
10. KALLAND T. (1986) Effects of immunomodulator LS2616 on growth and metastasis of the murine B16 F10 melanoma. Cancer Res 46, 3018.
11. KARUSSIS D.M., LEHMANN D., SLAVIN S. et al. (1993) Inhibition of acute experimental autoimmune encephalomyelitis by the synthetic immunomodulator Linomide. Ann Neurol 34, 654.
12. KARUSSIS D.M., LEHMANN D., SLAVIN S. et al. (1993) Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide). Proc Natl Acad Sci USA 90, 6400.
13. BAI X.F., SHI F.D., ZHU J., XIAO B.G., HEDLUND G. & LINK H. (1997) Linomide induced suppression of experimental autoimmune neuritis is associated with down-regulated macrophage functions. J Neuroimmunol 76, 177.
14. ZHANG G.X., Yu L.Y., SHI F.D. et al. (1997) Linomide suppresses both Th1 and Th2 cytokines in experimental autoimmune myasthenia gravis. J Neuroimmunol 73, 175.
15. KARUSSIS D.M., LEHMANN D., BRENNER T. et al. (1994) Immunomodulation of experimental autoimmune myasthenia gravis with Linomide. J Neuroimmunol 55, 187.
16. KLEINAU S., LARSSON P., BJORK J., HOLMDAHL R. & KLARESKOG L. (1989) Linomide, a new immunomodulatory drug, shows different effects on homologous versus heterologous collagen-induced arthritis in rats, Clin Exp Immunol 78, 138.
17. HORTELANO S., DIAZ-GUERRA M.J., GONZALEZ-GARCIA A. et al. (1997) Linomide administration to mice attenuates the induction of nitric oxide synthase elicited by lipopolysaccharide-activated macrophages and prevents nephritis in MRL/Mp-lpr/lpr mice. J Immunol 158, 1402.
18. SPETZ-HAGBERG A.L., GOLDSCHMIDT T.J., STALHANDSKE T. & LARSSON-SCIARD E.L. (1990) Amelioration of intrathymic T cell development and peripheral T cell reactivities in autoimmune mice undergoing therapy with a novel immunomodulator. Int Immunol 2, 645.
19. SPETZ-HAGBERG A.L. & LARSSON-SCIARD E.L. (1989) Decreased levels of pathogenic IgG anti-DNA antibodies in autoimmune mice after linomide treatment. Res Immunol 140, 517.
20. SLAVIN S., SIDI H, WEISS L., ROSENMAN E., KALLAND T. & GROSS D. (1993) Linomide, a new treatment for autoimmune diseases: the potential in type I diabetes. Diabetes/Metabolism Rev 9, 311.
21. KARUSSIS D.M., LEHMANN D., SLAVIN S. et al. (1995) Immunomodulation of autoimmunity by Linomide. Isr J Med Sci 31, 38.
22. CHAMPION B.R., PAGE K.R., PARISH N. et al. (1991) Identification of a thyroxine-containing self-epitope of thyroglobulin which triggers thyroid autoreactive T cells. J Exp Med 174, 363.
23. ENGVALL E. & PERLMANN P. (1971) Enzyme-linked immunosorbent assay (ELISA): quantitative assay of immunoglobulin G. Immunochemistry 8, 871.
24. GROSS D.J., SIDI H, WEISS L., KALLAND T., ROSENMANN E. & SLAVIN S. (1994) Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drug. Diabetologia 37, 1195.
25. LEHMANN D., KARUSSIS D.M., FLURESCO D. et al. (1996) Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis. J Neuroimmunol 74, 102.
26. HARACH H.R. & WILLIAMS E.D. (1995) Thyroid cancer and thyroiditis in the goitrous region of Salta, Argentina, before and after iodine prophylaxis. Clin Endocrinol 43, 701.
27. MATTERN T., FLAD H.D., BRADE L., RIETSCHEL E.T. & ULMER A.J. (1998) Stimulation of human T lymphocytes by LPS is MHC unrestricted, but strongly dependent on B7 interactions. J Immunol 160, 3412.
28. SHAH P.D., GILBERTSON S.M. & ROWLEY D.A. (1985) Dendritic cells that have interacted with antigen are targets for NK cells. J Exp Med 162, 625.
29. KARPUS W.J., LUKACS N.W., MCRAE B.L., STRIETER R.M., KUNKEL S.L. & MILLER S.D. (1995) An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis J Immunol 155, 5003.
30. SPRINGER T.A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301.
31. LARSSON E.L., JOKI A. & STALHANDSKE T. (1987) Mechanisms of action of the new immunomodulator LS2616 on T cell responses. Int J Immunopharmacol 9, 425.
32. KALLAND T., ALM G. & STALHANDSKE T. (1985) Augmentation of mouse natural killer cell activity by LS2616, a new immunomodulator. J Immunol 134, 3956.
33. ZHANG G.-X., Yu L.-Y., SHI F.-D. et al. (1997) Linomide suppresses both Th1 and Th2 cytokines in experimental autoimmune myasthenia gravis. J Neuroimmunol 73, 175.
34. ARAD G., KATZENELLENBOGEN M., LEVY R., SLAVIN S. & KAEMPFER R. (1996) Linomide, an immunomodulator that inhibits Th1 cytokine gene expression. Int Immunol 8, 1603.